Regulation of Vascular Endothelial Growth Factor A (VEGFA) levels is important for many gene therapy applications and has been under development for the treatment for conditions such as myocardial infarction and peripheral arterial disease. The gene discussed is VEGFA; the disease is peripheral arterial disease.